Dermata Therapeutics Inc. Gains 32.71%

Dermata Therapeutics Inc. (DRMA:NASDAQ) rocketted at $1.42, a gain of 32.7%. On Wed, Feb 09, 2022, DRMA:NASDAQ hit a New 2-Week Low of $1.07. The stock appeared on our News Catalysts scanner on Mon, Feb 07, 2022 at 01:26 PM in the 'INVESTOR UPDATE' category. From Thu, Jan 27, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days

The stock spiked on Wed, Nov 03, 2021 at $6.95 with a volume of 4M+.

About Dermata Therapeutics Inc. (DRMA:NASDAQ)

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.